ZOOM WEBINAR INFORMATION
- Follow this link to join the Zoom webinar: https://ucsf.zoom.us/j/91136106710?pwd=ODJUSHZaZHhPaTVYanplSlBiYzU3QT09
- Meeting ID: 911 3610 6710
- Password: 291652
Join us for our 10th annual Master of Translational Medicine (MTM) Final Symposium on June 5th from 9am-12:30pm Pacific Time.
The MTM Class of 2020 has spent the past year collaborating with UCSF faculty and industry sponsors to move medical devices and novel therapies closer to clinical use. This year’s symposium will feature nine student capstone teams describing their work on these exciting projects.
Be sure to register on our Eventbrite page!
|[09:00 – 09:30am]||Welcome and Opening Remarks from the MTM Faculty Director Shuvo Roy & MTM Executive Director Moose O’Donnell|
|[09:30 – 09:45am]||Pinpoint Science|
|[09:45 – 10:00am]||LookDeep Health|
|[10:00 – 10:15am]||Nephrosant|
|[10:15 – 10:25am]||Break, audience voting for first three presentations|
|[10:25 – 10:40am]||Voyage Biomedical|
|[10:40 – 10:55am]||Intravascular Bioartificial Pancreas (iBAP)|
|[10:55 – 11:10am]||Zordera|
|[11:10 – 11:20am]||Break, audience voting for next three presentations|
|[11:20 – 11:35am]||Vitruvian|
|[11:35 – 11:50am]||Spinal Interbody Device|
|[11:50 – 12:05pm]||Eysz|
|[12:05 – 12:10pm]||Break, audience voting for last three presentations|
|[12:10 – 12:15pm]||Closing Remarks|
MTM Team Members: Bria Bailey, MS, Ames Ma, Bradley Wait
Project Leader: Lisa Diamond (CEO of Pinpoint Science)
Pinpoint Science has developed a novel bioelectronic nanosensor-based platform for the detection of the SARS-CoV-2 virus from individuals with or without symptoms of infection. The purpose of this test is to aid in the rapid screening of individuals who may be suspected to have COVID-19. The intended use is point-of-care and point-of-need screening. Testing may be performed at any location, including point of care or need, clinical laboratories, hospitals, clinics, pharmacies, and triage sites.
Pinpoint Science believes that democratizing screening and improving access to accurate, affordable testing allows for early detection and enhances overall health management. The Pinpoint Science platform is simple to use. Using interchangeable cartridges and a reader device, the platform can detect the presence of viruses, bacteria, fungi, and other biomolecules in under one minute. In addition to COVID-19 virus tests, Pinpoint Science plans to develop COVID-19 antibody serology tests, and tests for influenza, IL6, and others. Our MTM team is assisting with funding applications, emergency use authorization, quality and project management, and creating device shell prototypes to further validate the technology, and helping expedite the process of getting the tests to market.
MTM Team Members: Philip A. Alves, MD, Brandon Shih, Xinyu Li
Project Leaders: Narinder Singh, Michael Choma
The typical hospitalized patient receives only several minutes of physician monitoring daily and status checks every several hours. Patient deterioration often occurs in the absence of clinical monitoring. With limited staff capacity, hospitals deploy non-clinical labor (i.e. patient sitters) at an excessive cost to increase monitoring of some patients without gaining any additional clinical insight. Our computer vision and machine learning technology provides continuous monitoring and real-time status updates to healthcare providers. The opportunity to increase monitoring for patients outside of an ICU without additional labor is dually beneficial for patients by reducing negative outcomes, and to health care settings by decreasing their financial burden.
MTM Team Members: Deepika Sarode, Olivia Prior Palomares, Zoë Hurtado, Raymond Dong
Project Leaders: Minnie Sarwal, MD (Professor, UCSF Division of Surgery; Founder and CEO of Nephrosant), Joshua Yang, MTM
Kidney stone disease (nephrolithiasis) is a common problem worldwide. In the Western world, the reported lifetime prevalence is 10–12% in men and 5–6% in women. Nephrolithiasis is largely a recurrent disease with a relapse rate of 50% in 5–10 years and 75% in 20 years. Relapses cannot be predicted with contemporary and burdensome 24-hour urine supersaturation collections, and this incurs significant financial costs for patients and the health care system. With the clinical unmet needs in mind, Nephrosant seeks to develop an innovative urine-based point-of-care (POC) dipstick device that can be used in the clinical and at-home settings and allow for personalized patient monitoring of kidney stone risk. MTM students are involved in all aspects of the project ranging from clinical test, regulatory and commercialization plans, and external industry collaborations.
MTM Team Members: Nitika Chellappa, Annam Quraishi, Akhilesh Yeluru
Project Leaders: Robert Shultz, MD, MTM, Justin Olshavsky, MTM, Bridget Vaughan, MTM (Co-Founders of Voyage Biomedical)
In the United States alone, there are an estimated 795,000 strokes per year. Every forty seconds, one person in the US will have a stroke and every four minutes one person will die as a result of their stroke. Although current treatments focus on removing blockages to blood flow causing stroke, there is a definitive clinical need for a bedside device that can further protect the brain before, during, and after blockage-removal treatment. We are working to change the paradigm of stroke care to improve patient outcomes by developing a catheter-based technology to selectively cool the brain. Normally cooling the brain is an invasive technique performed during cardiac surgery to protect the brain when the heart is stopped. We are taking the same brain cooling techniques out of the cardiac surgery OR and to the bedside to prevent brain damage during stroke.
Intravascular Bioartificial Pancreas (iBAP)
MTM Team Members: Nitasha Goyal, Nathan Ackermann, Brooke Stephanian
Project Leader: Charles Blaha (Research Associate, UCSF)
Currently ~10% of the US population (30.3 million Americans) have diabetes. Of this population, 5% of diabetic (1.25 million American) children and adults have type 1 diabetes. As the number of patients with T1D continues to increase, there is a need for a permanent treatment to prevent complications associated with diabetes such as uncontrolled hyperglycemic unawareness. Even with current solutions, Type 1 diabetics suffer from daily pin pricks, injections, or invasive surgeries that do not always achieve a long-term functional cure. The intravascular Bioartificial Pancreas (iBAP) is an intervention that will enable islet cells to achieve long-term control of blood glucose levels. The device utilizes a silicon nanopore membrane (SNM) allowing size selective admission of physiologically necessary molecules to sustain islet cells for insulin delivery while blocking the immune system from attacking the cells. This will provide patients enhanced and automated glucose control therefore achieving better outcomes while also reducing costs.
MTM Team Members: Ao-Mei Lee, Janak Jobanputra, Okuoma Idah, William Xie
Project Leaders: Murty Vyakarnam Ph.D., Dan Bernards Ph.D., Robert Bhisitkul M.D. Ph.D., Tejal Desai Ph.D. (Professor and Chair, UCSF Department of Bioengineering and Therapeutic Sciences)
Glaucoma is the leading cause of irreversible blindness worldwide and affects more than 3 million patients in the United States. Eye drops, the current standard of care, are efficacious in controlled studies but are not as effective in practice. The patient burdens associated with intense medication regimens, side-effects and inconvenient procedures for proper drop instillation result in a non-compliance rate as high as 50%. Zordera, therefore, aims to ease the burden of daily administered eye drops for glaucoma by developing a continuous drug delivery implant that lasts up to a year without any patient involvement. To gain direct insights from future stakeholders, we have carried out a voice of customer study which includes designing questionnaires, applying for the IRB review and conducting multiple interviews. This has enabled further optimization of the current prototype, development of strategic regulatory and clinical pathways as well as clinical adoption and reimbursement plans.
MTM Team Members: Dongheyok “Danny” Kim, Yujia “Emily” Zeng, Michele Lin
Project Leaders: Vinod Mahendroo, MBA (CEO, Vitruvian Medical Devices), David Young, MD (Professor, UCSF Division of Plastic and Reconstructive Surgery), Hobart Harris, MD (Professor, UCSF Division of General Surgery)
Pressure ulcers, also more commonly known as bedsores, affect up to ~2.5M patients annually in the U.S., and can cost up to ~$ 26 B in annual healthcare spending. However, despite the significant threat it poses to public health and the economy, the way we assess and manage chronic wounds has not changed for decades. The current standard of care, the Braden Scale, relies heavily on caregivers’ sight and touch, and is a highly subjective method that is susceptible to human variance and error.
Vitruvian hopes to modernize wound care and management with a noninvasive SMART bandage that can quantify skin tissue health via impedance spectroscopy to prevent pressure ulcers. We aim to provide a new standard for pressure ulcer care by providing personalized and objective measures of tissue damage that reduces economic and patient burdens.
Spinal Interbody Device
MTM Team Members: Malavika Shankar, Melissa Keller, Lindsey Milisits, Rhett Larson
Project Leaders: Alexis Dang, MD, (Associate Professor, UCSF Division of Orthopaedic Surgery), Alan Dang, MD, (Assistant Professor, UCSF Division of Orthopaedic Surgery)
Spinal fusion is a surgery performed to connect two or more vertebrae in your spine and involves techniques to mimic the normal healing process of broken bones. One technique that surgeons use for spinal fusion is to place a biocompatible implant aimed to enhance bone fusion between the space of the spinal vertebrae. Approximately 40% of patients experience complications from spinal fusion surgery. These complications include either implant subsidence into the bone or failure to fuse, often leading to half of these patients requiring subsequent surgeries. Our team aims to reduce current device complications and decrease the rate of repeat surgeries in patients with a novel spinal implant design. We are utilizing computer assisted design and titanium 3D printing to develop a spinal interbody device specifically for lumbar fusion surgeries with a proprietary UCSF anisotropic lattice design based upon trabecular bone structure. The current design features will allow for long-term stability, high rate of bone fusion, decreased subsidence and reduced pain. The ultimate goal is to create a viable product that can be integrated into current surgical practices and enhance the spinal market.
MTM Team Members: Julia Martinez Franks, Wei-Kai Lin, MD, Mathias Vissers, MD
Project Leaders: Rachel Kuperman (Founder, CEO of Eysz, Inc.)
Diagnosing an epileptic seizure outside of the hospital is like detecting a fever without a thermometer. The gold standard for seizure detection is a video-EEG in the hospital, capturing only a fraction of the patient’s story. The lack of objective outpatient data on the frequency of seizures and pharmaceutical side effects at home often leads to the under- or overtreatment of epilepsy, causing a reduced quality of life, unnecessary hospitalizations, or even death. We are developing software algorithms that can detect and predict seizures using oculometric data (eye movement) by employing machine learning capabilities. We intend our product to easily interface and/or integrate with consumer grade eye-tracking systems (eg. smart glasses) and therapeutic devices (eg. neuromodulation) outside of a hospital setting. We are targeting the detection of absence seizures first, which are characterized by short lapses of consciousness. We aim to assist clinicians to remotely detect seizures and assess whether treatments reduce the frequency of seizures, thus decreasing risk of injury, and improving productivity and quality of life for people with epilepsy.
Shuvo Roy, PhD
Faculty Director of the MTM Program
Dr. Shuvo Roy is the Faculty Director of the MTM Program, a professor in the UCSF Department of Bioengineering and Therapeutic Sciences (BTS), and director of the Biodesign Laboratory at the Mission Bay Campus. He is the Technical Director of The Kidney Project, a national research project with a goal to create a small, surgically implanted, and free-standing bioartificial kidney to treat end-stage renal disease.
Michael “Moose” O’Donnell, PhD
Executive Director of the MTM Program
Moose O’Donnell is the Executive Director of the MTM Program working across both campuses to create the joint University experience for the students. He also oversees recruitment of new projects for MTM teams; to discuss sponsoring a project, please contact him at email@example.com.
Dan Burnett, MD, MBA
Industry Director of the MTM Capstone Course
Dr. Burnett, a CEO of ThereNova, received his M.D. from Duke University and concurrently obtained an M.B.A. from Duke’s Fuqua School of Business. Since 2006 Dr. Burnett has raised over $100MM for the seven TheraNova spinouts. He is an inventor on 15 issued patents and over 200 patents pending worldwide. He recently joined University of California San Francisco as an entrepreneur in residence with QB3 and as adjunct faculty in the Bioengineering Department.
Prior to pursuing an MTM, Nathan graduated with a B.S. in Biomedical Engineering and a minor in Computer Engineering from Boston University. Nathan has worked in the biotech space at Bioverativ as a supply chain intern, UCSF Innovation Ventures as a Catalyst intern, and First Principles Advisory Group as a consultant intern. Additionally, he has 3 years of experience in academic research labs. Nathan looks to leverage all of these experiences to launch a meaningful career in the biotech industry, bringing therapies to patients in need.
Plans after graduation: Nathan will be working at Amgen in Thousand Oaks, California as a Clinical Manufacturing Associate, executing upstream processes to support the production of a portfolio of therapies. Nathan’s LinkedIn
|Philip A. Alves, MD
Dr. Alves is a family physician interested in the intersection of business, technology, and medicine. He completed his Honours degree in psychology at the University of Toronto, followed by his MD and family medicine residency training at the University of Western Ontario. His professional interests include physician leadership in private and public health care systems.
Plans after graduation: Dr. Alves is currently working with several telemedicine platforms and continues to seek consulting opportunities to improve clinical access and health outcomes. Philip’s LinkedIn
|Bria Bailey, MS
Bria is a clinical researcher by trainings and earned her first master’s degree in Biophysics and Physiology with a concentration in Complementary and Alternative. While in graduate school, she worked as a research assistant focusing on HIV/AIDS in NIAID at the NIH. More recently, I worked as a neonatal neurology at UCSF and user success associate at Alphabet’s biotech subsidiary–Verily Life Sciences.
Plans after graduation: After graduating, Bria plans to apply design thinking methodology to improve primary health outcomes from underrepresented communities. Bria’s LinkedIn
Nitika is an American Association of University Women fellow at the Master of Translational Medicine (MTM) program. Through the MTM program, she has been working with Voyage Biomedical where she has been developing the clinical, market, and regulatory strategies for a catheter device to prevent brain damage during stroke. Prior to joining the MTM, Nitika obtained her B.S. in bioengineering from UCLA (’19) and held a summer internship at Roche developing a Next Generation Sequencer. Nitika aims to continue innovating tools for clinicians to improve the quality of medicine.
Plans after graduation: Nitika is seeking clinical development or field clinical engineering roles at the intersection of R&D and clinical needs-finding. Nitika’s LinkedIn
Raymond joined the MTM program with a B.S. in Bioengineering from UC San Diego and experience working at UCSD Health, Arcturus Therapeutics, and Johnson & Johnson. This year, he worked on Nephrosant’s kidney stone management solution and contributed significantly to market research and clinical data management. He is also part of a physician-led team in UC San Francisco, supporting go-to-market strategy and technical development of an advanced AI algorithm for ultrasound diagnostics. He is passionate about bringing novel technologies to the real world for true impact on clinicians and patients.
Plans after graduation: After graduation, Raymond is looking forward to taking on a position where he can apply skills in data science to support business processes and healthcare innovations. Raymond’s LinkedIn
Nitasha’s background in neuroscience, bioengineering, and neurotechonology has led her to multiple opportunities in research and innovation. While at UCSF she published 2 papers on developmental neuroscience in Nature and Science. She then worked at Imperial College, conducting research on using a novel device to modulate neural processes to reverse neurodegeneration. Inspired by her experience volunteering in lower-resourced areas, she along with other students developed a mobile diagnostic tool that could help identify parasitic diseases in areas with limitations in equipment and access to healthcare facilities.
Plans after graduation: Her interests not only lie in neurotechonology but also in using clinical experience to discover the limitations in administering healthcare in lower – resourced areas and using her engineering background to help create solutions. In the fall, she will be attending SUNY Downstate Medical School to pursue her goal of becoming a neurosurgeon. Nitasha’s LinkedIn
With a BS degree in biophysics from Wake Forest University and now an MTM degree, Zoë has gained both technical and business skills to be effective in cross-functional teams. She not only has research experience in the lab but is also skilled at project management, market research, and planning go-to-market strategies. She is passionate about consumer health, wearable devices, and telehealth products and strives to become a project manager. Ultimately, her mission is to improve access to healthcare and change the medical care paradigm from treatment to prevention.
Plans after graduation: Zoë is seeking employment as a project manager. Zoë’s LinkedIn
Okuoma is an early career professional with diverse experience in the healthcare industry. After earning a B.S. in Biomedical Engineering from Brown University (’16), he spent two years in healthcare consulting followed by a year in biotechnological product development. Through the MTM, he has leveraged data analysis and market research to advance strategic decision making for the development of Zordera’s implantable drug delivery technology.
Plans after graduation: Okuoma aims to continue operating across functions, analyzing and interpreting data, and driving process optimization to expedite and improve delivery of innovative solutions to patients. Okuoma’s LinkedIn
Janak Jobanputra is a highly motivated, detail oriented graduating student in the MTM Program. After completing a bachelor’s degree in Biomedical Engineering and Computer Science at UC Davis, he has worked as a software developer for three years, developing his computer science and data analysis skills at health data startups in the Bay Area. After the MTM program, Janak aims to work on medical devices with a computer science aspect, allowing him to draw from his biomedical engineering and software skillsets to create innovative solutions.
Plans after graduation: Janak will be joining Abbott Diabetes Care as a Technical Program Manager! Janak’s LinkedIn
Melissa is technically trained as a bioengineer from UC San Diego. Prior to the MTM program, Melissa worked in engineering and preclinical research at a bioresorbable scaffold company and in consulting at a medical device development company. In addition to her project of designing a novel spinal device, Melissa developed a rehabilitation device for contracture prevention with a team of engineering students at UC Berkeley. She hopes to assist in the specialization of devices and treatments for patients and find a position interfacing the clinical and engineering fields after graduation.
Plans after graduation: Melissa is looking for a position in California translating medical technology into clinical application. She hopes to interact in both the engineering and clinical fields, implementing new medical advancements that improve the quality of life of patients. Melissa’s LinkedIn
|Donghyeok “Danny” Kim
Danny attended UCLA as an undergraduate biochemistry major. During his time at UCLA, he worked worked at a bioengineering lab for 4 years to publish two works in cytometry imaging using deep learning in Nature and rapid microfluidic cancer diagnostics in ACS. At the same time, he interned at St. John’s neurosurgical department and worked analyzing clinical data for improved surgical outcomes. In his free time, he volunteers at the Venice Family Clinic to help working class families and homeless to get the healthcare they need. Currently, he is focused on data-driven healthcare outcomes and believes that AI and data can bring an unprecedented level of access to healthcare to all families at a low cost.
Plans after graduation: Danny is looking to work as a data scientist in the healthcare industry. Danny’s LinkedIn
Rhett is a Second Lieutenant in the United States Army National Guard with a B.S. in Mechanical Engineering and a minor in Applied Mathematics from the University of Portland. Rhett has 3 years of academic research experience, as well as, an apprentice electrician license. He is seeking employment opportunities in the healthcare industry in Product Development/Management or Design utilizing his mechanical/biomedical engineering and trade work expertise, along with leadership attributes gained from military training, to bridge the gaps between clinical needs, engineering, and commercialization.
Plans after graduation: After graduating, Rhett will attend Basic Officer Leadership Course in Ft. Leonard Wood, MO. Once he returns he will pursue employment in Seattle, WA in the medical device space. Rhett’s LinkedIn
Ao-Mei is a trained chemist and biologist with many years of laboratory experience. To satisfy her curiosity about translating an idea into a commercial product, she has come to the Bay Area and learned directly from industry experts. Besides graduate studies, she also worked as a team project manager, a scientific consultant and a lab technician (during the pandemic). Her current interests include, but are not limited to, clinical and regulatory strategy as well as project management.
Plans after graduation: Gain experience as a scientist in the industry. Move towards management roles. Ao-Mei’s LinkedIn
Xinyu Li graduated from University of Pittsburgh at 2019. Her background was in medical device. She is currently a student at UC Berkeley and UCSF.
Plans after graduation: Xinyu will be working for Wechat as a Product manager in China. Xinyu’s LinkedIn
Michele is a cancer biologist and UX researcher. She received her B.S. in Toxicology from UC Berkeley and will soon receive her masters in translational medicine from UCSF/Berkeley. She has 4 years of research experience on tumor organoids & CAR-T therapy, and is currently the design lead for Vitruvian Biomedical Devices. She is also familiar with quantitative and qualitative UX research methods, and looks forward to combining her research experience with her skills in user centered design to find creative solutions for challenges in healthcare.
Plans after graduation: Michele is currently looking for UX research roles in healthcare. Michele’s LinkedIn
Wei-Kai is an MD with skills in machine learning. He has years of experience practicing as a general physician and served as a volunteer doctor in Africa. His passion is in combining medicine with technology and has done research in implementing artificial intelligence in medicine. He will continue his pursuit of providing a better and more accessible medical care for people in need.
Plans after graduation: Seeking a position in industry to utilize the skills learnt in healthcare innovations. Wei-Kai’s LinkedIn
Ames is an interdisciplinary designer and scientist interested in making medical devices more user-friendly and accessible.
Plans after graduation: Seeking roles in human factors engineering for medical devices as well as general HIV/infectious diseases focused research. Ames’s LinkedIn
|Julia Martinez Franks
Trained as a biologist, Julia is a highly motivated individual who is passionate about medical device development. At age 15, she co-founded More Than Just Me, a non-profit in partnership with Oakland Children’s Hospital dedicated to helping patients in need. This experience sparked her passion to pursue a career in the medical field. Julia received her Bachelor’s in Biology from Vassar College, and is currently a Master of Translational Medicine student at UC Berkeley and UCSF. During her time in the program, she has been working with Eysz on the development of software algorithms to detect seizures using oculometric data.
Plans after graduation: Julia is continuing her work with Eysz, doing customer discovery and product management. She is seeking opportunities in product development in the Bay Area. Julia’s LinkedIn
Lindsey has four years of experience within consulting and clinical disciplines and holds a B.S. from Carnegie Mellon University in Materials Science and Biomedical Engineering. Prior to graduate school, Lindsey was a Clinical Research Coordinator at Dana Farber Cancer Institute where she managed clinical trials within the Breast Oncology Center. She is currently working at First Principles Advisory Group, a biopharma management consultancy. Lindsey is interested in designing and enhancing the user experience of healthcare products and hopes to continue her career in product management within healthcare innovation.
Plans after graduation: Lindsey is currently working for First Principles Advisory Group, a biopharma management consultancy. However, after graduation she is interested in shifting to a role within product management or human factors engineering in the healthcare space. Lindsey’s LinkedIn
Olivia Prior Palomares
Olivia holds a BSc in Biomedical Engineering from University of Barcelona. She has experience in contributing to the identification of unmet clinical needs and using innovative technology to try to solve them. In particular, her thesis involved the use of augmented reality in oncologic surgeries. After MTM, Olivia plans to pursue research on the use of nanodevices for early detection of ovarian cancer. She hopes one day she can apply what she learnt during her MTM year and actually translate her research to the clinic.
Plans after graduation: Olivia will be doing a PhD in Biomedical Engineering in Barcelona. Her research will focus on the use of nanodevices for early detection of ovarian cancer. Olivia’s LinkedIn
Annam joined the MTM program after graduating from UC Berkeley with her B.S Bioengineering (’19). She has over three years experience growing startups using the Lean Startup Methodology at Haas to help find product market-fit. Over the years, she has worked in Regulatory and Quality roles in med-tech as well as worked on her own startup NeuroGuard. She is excited to bridge the gap in medicine by addressing customer’s needs and leave a lasting impact on health.
Plans after graduation: After graduation, she will be following her passion for startups by teaching the lean startup method to freshmen on the side while pursuing a transitional role at Varian full-time where as a Post Market Surveillance Analyst for the EU MDR. Annam’s LinkedIn
Deepika has a B.A. in Molecular and Cellular Biology from UC Berkeley and experience as a researcher in blood-biomaterials interactions for medical devices at UCSF. In her MTM year, she worked with NephroSant to develop the business model and design a retrospective validation study for their kidney stone diagnostic. Deepika’s goal is to be a physician that makes an impact in developing accessible medical devices for the pediatric population.
Plans after graduation: After graduation from the MTM, Deepika is starting her medical training at the University of Southern California. She is currently interested in working with later stage startups to design clinical studies for FDA approval. Deepika’s LinkedIn
Malavika has over two years of healthcare consulting experience working with large hospital systems to improve business processes within the revenue cycle. Malavika hopes to utilize her practical industry knowledge as well as her product-focused capstone project experience to help improve access and delivery of care through the use of novel, consumer-driven health technologies.
Plans after graduation: After graduation, Malavika intends to leverage her experience and skills from the MTM program to focus on a career in product management and entrepreneurship. Mala’s LinkedIn
Brandon has a B.S. in Bioengineering from UCLA with over two years of academic research addressing clinical problems through engineering applications, specifically in the realm of drug delivery devices. With the goal of creating a larger clinical impact in this era of digital health, he worked with LookDeep Health to develop an AI model to help improve situational awareness across inpatient populations. He hopes to continue leveraging his bioengineering background and knowledge in data science to pursue data-centric opportunities in improving current medical technology, generating a positive impact on patient’s lives.
Plans after graduation: After graduation, Brandon is seeking opportunities that allow him to interweave my background in bioengineering and data science to develop clinical solutions through various pathways such as diagnostics and medical device validation. Brandon’s LinkedIn
|Mathias Vissers, MD
Mathias is a Belgian physician with a strong interest in neurology, technology and entrepreneurship. Even as a student he designed and led multiple neuroscientific research projects at KU Leuven and Harvard. He is currently working on his digital health startup for smartphone-driven physical therapy.
Plans after graduation: Mathias is always looking for interesting roles where can combine his passion for medicine, neurotechnology and entrepreneurship. Mathias’s LinkedIn
Bradley is a bioengineer, inventor and skilled engineering manager holding Masters degrees from Stanford University in both Biological Sciences and Electrical Engineering. He joined the MTM Program to synthesize his general technical, engineering and business innovation experience with an expanded understanding of bioengineering and innovative thinking in that realm. Bradley is an innovative thinker with a track record of startup and big business success, and he enjoys leading cross-disciplinary teams to achieve tactical and strategic goals. Keen to apply his broad expertise to the field of biomedical science, Bradley is seeking opportunities to help advance medical technology and improve patient care.
Plans after graduation: Bradley seeks opportunities to apply his broad expertise to the field of biomedical science to help advance medical technology and improve patient care. Bradley’s LinkedIn
Akhilesh Yeluru is a bioengineering graduate from UCSD and future surgeon who loves solving problems. As part of the Voyage Biomedical MTM capstone team, he had the opportunity to explore this passion by helping the team transform a highly invasive cardiac surgery technique into, potentially, the standard of stroke care.
Plans after graduation: He will be attending medical school next year and looks forward to further impacting the medical industry through research, innovation, and entrepreneurship. Akhilesh’s LinkedIn
Experienced neuroscience research assistant currently studying translational medicine in the Bay Area. Passionate about MedTech and actively seeking chances to join the community with my interdisciplinary background in life science research, clinical understanding and business strategies. Undoubtedly an easygoing, open-minded team player with my international study and internship experience across United States, Canada, Germany and China.
Plans after graduation: Emily has landed a research position in her hometown city, Chengdu, China. She’s open to both staying in research and transiting to industry, depending on the chances she will have in the next year or two. Emily’s LinkedIn